ArticleJournal of virology2026
Filamentous virions act as non-infectious interfering particles to modulate papillomavirus infection.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Genus beta (β) human papillomaviruses (HPVs) potentially contribute to the development of non-melanoma skin cancer. Yet, comparatively little is known about their biology. In particular, details about initial infection, i.e., host cell entry, remain mostly elusive. During initial characterization of β HPV5 pseudovirion (PsV) preparations, surprisingly large amounts of filamentous particles were found besides the prototypical icosahedral (T = 7) virions. Whether these filamentous particles actively contribute to or interfere with infectivity of the spherical viruses is unknown. Using a combination of morphological, biochemical, and virological methods, we showed that the filamentous particles are non-infectious. Moreover, they interfered with the initial step of infection, i.e., binding to cellular heparan sulfate proteoglycans (HSPGs), and served as a decoy for soluble glycosaminoglycans, thereby modulating infectivity by enhancing infectious PsV binding. This explains previous seemingly contradictory findings on HPV5 binding to HSPGs. Importantly, in HPV5 skin warts from an immunocompromised patient, no filamentous particles were observable highlighting differences in the assembly of pseudovirions and native viruses.IMPORTANCEPapillomaviruses contribute to numerous cancer incidents and significant mortality despite available vaccinations. Hence, high-risk α HPVs have been the focus of most research in the past. However, there are indications that less well-studied β HPVs may also contribute to certain malignancies. Little is known about their mode of cell invasion, and available data appear partially contradictory. Our work demonstrated that HPV5 as a model β HPVs yielded high amounts of non-infectious filamentous particles during PsV production. These acted as modulators of infection by the infectious spherical particles. Removing these filamentous particles showed that HPV5 engaged HSPGs as the primary receptor for cell binding, similar to high-risk α HPV, indicating a conserved feature not only among α, but also among β HPVs, thereby explaining previous contradictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.